(0.06%) 5 157.75 points
(0.08%) 38 862 points
(-0.04%) 17 993 points
(0.49%) $78.49
(0.47%) $2.15
(0.50%) $2 320.10
(1.89%) $27.20
(-0.21%) $963.30
(0.06%) $0.929
(0.03%) $10.88
(0.03%) $0.797
(0.41%) $91.83
Live Chart Being Loaded With Signals
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions...
Stats | |
---|---|
Dagens volum | 5 053.00 |
Gjennomsnittsvolum | 2 766.00 |
Markedsverdi | 46.40M |
EPS | $0 ( 2024-03-13 ) |
Neste inntjeningsdato | ( $0 ) 2024-07-10 |
Last Dividend | $0.0300 ( 2018-01-05 ) |
Next Dividend | $0 ( N/A ) |
P/E | 70.00 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-27 | Michel Robert J | Buy | 750 | Daxor Common Stock |
2024-03-04 | Feuer Edward | Buy | 1 000 | Daxor Common Stock |
2023-12-06 | Michel Robert J | Buy | 120 | Daxor Common Stock |
2023-12-01 | Michel Robert J | Buy | 180 | Daxor Common Stock |
2023-12-01 | Feldschuh Michael Richard | Buy | 800 | Daxor Common Stock |
INSIDER POWER |
---|
56.67 |
Last 97 transactions |
Buy: 668 992 | Sell: 434 444 |
Daxor Corp Korrelasjon
10 Mest positive korrelasjoner |
---|
10 Mest negative korrelasjoner |
---|
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Daxor Corp Økonomi
Annual | 2023 |
Omsetning: | $34.59M |
Bruttogevinst: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2023 |
Omsetning: | $34.59M |
Bruttogevinst: | $34.41M (99.49 %) |
EPS: | $0.0606 |
FY | 2022 |
Omsetning: | $6.31M |
Bruttogevinst: | $5.22M (82.77 %) |
EPS: | $1.270 |
FY | 2021 |
Omsetning: | $5.82M |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $1.170 |
Financial Reports:
No articles found.
Daxor Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.500 | 1997-04-28 |
Last Dividend | $0.0300 | 2018-01-05 |
Next Dividend | $0 | N/A |
Payout Date | 2018-01-12 | |
Next Payout Date | N/A | |
# dividends | 20 | -- |
Total Paid Out | $5.11 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.17 | -- |
Div. Sustainability Score | 2.66 | |
Div.Growth Potential Score | 0.487 | |
Div. Directional Score | 1.571 | -- |
Year | Amount | Yield |
---|
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
HNW | Ex Dividend King | 2023-08-17 | Monthly | 0 | 0.00% | |
PFIX | Ex Dividend Knight | 2023-08-28 | Monthly | 0 | 0.00% | |
CVR | Ex Dividend Junior | 2023-09-01 | Quarterly | 0 | 0.00% | |
GGN | Ex Dividend Knight | 2023-10-16 | Monthly | 0 | 0.00% | |
NML | Ex Dividend Knight | 2023-09-14 | Monthly | 0 | 0.00% | |
CIX | Ex Dividend King | 2023-08-31 | Quarterly | 0 | 0.00% | |
EVV | Ex Dividend King | 2023-09-08 | Monthly | 0 | 0.00% | |
NBH | Ex Dividend Knight | 2023-09-28 | Monthly | 0 | 0.00% | |
UTG | Ex Dividend Knight | 2023-08-17 | Monthly | 0 | 0.00% | |
BOAT | Ex Dividend Junior | 2023-06-27 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0121 | 1.500 | 9.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0121 | 1.200 | 9.60 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0131 | 1.500 | -0.966 | -1.449 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.251 | 0.800 | -3.74 | -3.00 | [1 - 3] |
quickRatioTTM | 0.138 | 0.800 | -3.90 | -3.12 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0.0217 | -1.500 | 9.64 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -6.56 | 1.000 | -3.54 | -3.54 | [3 - 30] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.856 | -1.712 | [0 - 20] |
debtEquityRatioTTM | 0.0222 | -1.500 | 9.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.987 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.00928 | 1.000 | -2.19 | -2.19 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -10.89 | 1.000 | -10.00 | -10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.994 | 0.800 | 6.70 | 5.36 | [0.5 - 2] |
Total Score | 2.66 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 111.89 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0131 | 2.50 | -0.621 | -1.449 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.712 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -1.712 | 2.00 | -0.571 | -1.141 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.286 | 1.500 | 4.76 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.237 | 1.000 | -8.43 | 0 | [0.1 - 0.5] |
Total Score | 0.487 |
Daxor Corp
Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.